Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis

Walter H. Reinhart; Linda Zehnder; Thomas Schulzki

doi:10.1160/TH08-04-0207

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2009; 101(04): 720-723
DOI: 10.1160/TH08-04-0207

Platelets and Blood Cells

Schattauer GmbH

Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis

Walter H. Reinhart

¹Department of Internal Medicine, Kantonsspital Graubünden, Chur, Switzerland

,

Linda Zehnder

¹Department of Internal Medicine, Kantonsspital Graubünden, Chur, Switzerland

,

Thomas Schulzki

²Blood Tranfusion Service SRC Graubünden, Chur, Switzerland

› Author Affiliations

Abstract

Summary

Primary haemostasis is mediated by platelet aggregation. Red blood cells (RBCs) are involved in this process. We hypothesised that stored RBCs could have less capacity to support primary haemostasis. This was tested with RBC units from 17 healthy volunteers stored for 45 days. Fresh citrated blood was taken again from the same donors and platelet-rich plasma was prepared, in which RBCs were resuspended with a constant haematocrit (40%), but changing fractions of stored versus fresh auto-logous RBCs (0, 25, 50, 75, and 100%, respectively). A platelet function analyser PFA-100^® was used. In this instrument blood is aspirated through a membrane pore coated with collagen and either epinephrine (EPI) or ADP, which causes platelets to adhere, aggregate, and form an occluding plug, which stops blood flow and is measured as closure time (CT). We found that the CT increased with increasing fractions of stored blood. CT-EPI was 121 ± 17 seconds [s], 129 ± 32 s, 164 ± 45 s (p< 0.000, ANOVA), 214 ± 54 s (p< 0.0001), and 273 ± 36 s (p< 0.0001) for 0, 25, 50, 75, and 100% stored RBCs. For CT-ADP the values were 91 ± 22 s, 95 ± 12 s, 101 ± 13 s, 124 ± 44 s (p= 0.004), and 191 ± 72 s (p< 0.0001), respectively. We conclude that stored RBCs have less capacity than normal RBCs to support primary haemostasis by platelet aggregation in vitro, suggesting a decreased capacity of stored RBCs to bring platelets into close contact with the wall, which may contribute to sustained bleeding seen after mass transfusion.

Keywords

Erythrocyte - haemostasis - platelet - platelet aggregation - trans-fusion

Full Text

References

References
1 Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611-616.
2 Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961; 7: 42-50.
3 Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980; 207: 541-543.
4 Turitto VT, Weiss HJ. Platelet and red cell involvement in mural thrombogenesis. Ann NY Acad Sci 1983; 416: 363-376.
5 Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood 1984; 6: 1200-1206.
6 Eugster M, Reinhart WH. The influence of the haematocrit on primary hemostasis in vitro. Thromb Haemost 2005; 94: 1213-1218.
7 Goldsmith HL. The flow of model particles and blood cells and its relation to thrombogenesis. Prog Hemost Thromb 1972; 1: 97-127.
8 Aarts PA, Heethaar RM, Sixma JJ. Red blood deformability influences platelets-vessel wall interaction in flowing blood. Blood 1984; 64: 1228-1233.
9 Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-Report – Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis. Thromb Haemost 1986; 55: 415-435.
10 Eckstein EC, Belgacem F. Model of platelet transport in flowing blood with drift and diffusion terms. Biophys J 1991; 60: 53-69.
11 Jordan A, David T, Homer-Vanniasinkam S. et al. The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow. Biorheology 2004; 41: 641-653.
12 Zhao R, Kameneva MV, Antaki JF. Investigation of platelet margination phenomena at elevated shear stress. Biorheology 2007; 44: 161-177.
13 Kim S, Kong RL, Popel AS. et al. Temporal and spatial variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol 2007; 293: H1526-1535.
14 Cokelet GR, Goldsmith HL. Decreased hydrodynamic resistance in the two-phase flow of blood through small vertical tubes at low flow rates. Circ Res 1991; 68: 1-17.
15 Santos MT, Valles J, Marcus AJ. et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991; 87: 571-580.
16 Valles J, Santos MT, Aznar J. et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood 1991; 78: 154-162.
17 Sollberger T, Walter R, Brand B. et al. Influence of prestorage leucocyte depletion and storage time on rheologic properties of erythrocyte concentrates. Vox Sang 2002; 82: 191-197.
18 Singh A, Reinhart WH. The influence of fractions of abnormal erythrocytes on aggregation. Eur J Clin Invest 1991; 21: 597-600.
19 Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005; 89: 123-127.
20 Levy JH. Massive transfusions coagulopathy. Semin Hematol 2006; 43: S59-63.
21 Arnaud F, Handrigan M, Hammett M. et al. Coagulation patterns following haemoglobin-based oxygen carrier resuscitation in severe uncontrolled haemorrhagic shock in swine. Transfus Med 2006; 16: 290-302.
22 Zehnder L, Schulzki Th, Goede J. et al. Erythrocyte storage in hypertonic (SAGM) or isotonic (PAGGSM) conservation medium: Influence on cell properties. Vox Sanguinis 2008; 95: 280-287.
23 Kundu SK, Heilmann EJ, Sio R. et al. Description of an in vitro platelet function analyzer- PFA-100. Semin Thromb Hemost 1995; 21: 106-112.
24 Reinhart WH, Chien S. Red cell rheology in stomatocyte – echinocyte transformation: Roles of cell geometry and cell shape. Blood 1986; 67: 1110-1118.
25 Berezina TL, Zaets SB, Morgan C. et al. Influence of storage on red blood rheological properties. J Surg Res 2002; 102: 6-12.
26 Klein HG, Spahn DR, Carson JL. Transfusion Medicine 1. Red blood cell transfusion in clinical practice. Lancet 2007; 370: 415-426.
27 Relevy H, Koshkaryev A, Mamny N. et al. Blood banking-induced alteration of red blood cell flow properties. Transfusion 2008; 48: 136-146.
28 Walter R, Brand B, Mark M. et al. Effects of leucocyte depletion on rheologic properties of human CPDA-1 blood. Vox Sang 2000; 79: 151-155.
29 Bishop JJ, Nance PR, Popel AS. et al. Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules. Am J Physiol Heart Circ Physiol 2004; 286: H113-120.
30 Joist JH, Bauman JE, Sutera SP. Platelet adhesion and aggregation in pulsatile shear flow: effects of red blood cells. Thromb Res 1998; 92: S47-52.
31 Goldsmith HL, Bell DN, Spain S. et al. Effect of red blood cells and their aggregates on platelets and white cells in flowing blood. Biorheology 1999; 36: 461-468.
32 Zhou R, Chang HC. Capillary penetration failure of blood suspensions. J Colloid Interface Sci 2005; 287: 647-656.
33 Wuillemin WA, Gasser KM, Zeerleder SS. et al. Evaluation of a platelet function analyzer in patients with a bleeding tendency. Swiss Med Wkly 2002; 132: 443-448.
34 Wagner GM, Chiu DT, Yee MC. et al. Red cell vesiculation -- a common membrane physiologic event. J Lab Clin Med 1986; 108: 315-324.
35 Franchini M. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis. Hematology 2005; 10: 177-181.
36 Alberts MJ, Bergman DL, Molner E. et al. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004; 35: 175-178.
37 Hobikoglu GF, Norgaz T, Aksu H. et al. The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy. Can J Cardiol 2007; 23: 201-206.
38 Crescente M, Di Castelnuovo A, Iacoviello L. et al. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A meta-analysis of 19 studies comprising 3,003 patients. Thromb Haemost 2008; 99: 1129-1131.
39 Valeri CR, Ragno G. In vitro testing of platelets using the thromboelastogram, platelet function analyzer, and the clot signature analyzer to predict the bleeding time. Transfus Apher Sci 2006; 35: 33-41.
40 Van Vliet HHDM, Kappers-Klunne MC, Leebeek FWG. et al. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. Thromb Haemost 2008; 100: 462-468.
41 Feuring M, Schultz A, Losel R. et al. Montoring acetylsalicylic acide effects with the platelet function analyzer PFA-100. Semin Thromb Hemost 2005; 31: 411-415.
42 Crescente M, Di Castelnuovo A, Iacoviello L. et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008; 99: 14-26.
43 Tonda R, Lopez-Vilchez I, Navalon F. et al. Platelets interact with tissue factor immobilized on surfaces: effects of shear rate. Eur J Clin Invest 2008; 38: 34-42.
44 Koch CG, Li L, Sessler DI. et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.